Effects of gastroprotectant drugs for the prevention and treatment of peptic ulcer disease and its complications: a meta-analysis of randomised trials

Inflammatory Bowel Disease

Frequency and type of drug-related side effects necessitating treatment discontinuation in the Swiss Inflammatory Bowel Disease Cohort

Eur J Gastroenterol Hepatol.

Godat S, Fournier N, Safroneeva E, Juillerat P, Nydegger A, Straumann A, Vavricka S, Biedermann L, Greuter T, Fraga M, Abdelrahman K, Hahnloser D, Sauter B, Rogler G, Michetti P, Schoepfer AM, Swiss IBD Cohort Study Group

doi: 10.1097/MEG.

COMMENTED

Inflammatory Bowel Disease

Adverse Events and Nocebo Effects in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

J Crohns Colitis.

Ma C, Panaccione NR, Nguyen TM, Guizzetti L, Parker CE, Hussein IM, Vande Casteele N, Khanna R, Dulai PS, Singh S, Feagan BG, Jairath V

doi: 10.1093/ecco-jcc/jjz087.

RECOMMENDED

Inflammatory Bowel Disease

Predicting, Preventing, and Managing Treatment-related Complications in Patients With Inflammatory Bowel Diseases

★ 3 Recommended by Prof. Dr Stephan Vavricka, Faculty Member

Clin Gastroenterol Hepatol.

Beaugerie L, Rahier JF, Kirchgesner J

doi: 10.1016/j.cgh.2020.02.009.

Inflammatory Bowel Disease

Histologic Healing Rates of Medical Therapies for Ulcerative Colitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Am J Gastroenterol.

Battat R, Duijvestein M, Guizzetti L, Choudhary D, Boland BS, Dulai PS, Parker CE, Nguyen TM, Singh S, Casteele NV, Pai RK, Feagan BG, Sandborn WJ, Jairath V

doi: 10.14309/ajg.

ColonoscopyGastrointestinal CancerInflammatory Bowel Disease

Misoprostol for small bowel ulcers in patients with obscure bleeding taking aspirin and non-steroidal anti-inflammatory drugs (MASTERS): a randomised, double-blind, placebo-controlled, phase 3 trial

Lancet Gastroenterol Hepatol.

Taha AS, McCloskey C, McSkimming P, McConnachie A

doi: 10.1016/

Helicobacter Pylori

Helicobacter pylori increases the risk of low-dose aspirin ulcers: A meta-analysis

J Gastroenterol Hepatol.

Sarri GL, Grigg SE, Yeomans ND

doi: 10.1111/jgh.14539.

Helicobacter Pylori

Helicobacter pylori-associated peptic ulcer disease: A retrospective analysis of post-treatment testing practices

Helicobacter.

Feder R, Posner S, Qin Y, Zheng J, Chow SC, Garman KS

doi: 10.1111/hel.12540.

Inflammatory Bowel Disease

Benefit-Risk Assessment of Vedolizumab in the Treatment of Crohn's Disease and Ulcerative Colitis

Drug Saf.

Battat R, Ma C, Jairath V, Khanna R, Feagan BG

doi: 10.1007/s40264-018-00783-1.

Inflammatory Bowel DiseaseFurther Publications

Telemonitoring of Crohn's Disease and Ulcerative Colitis (TECCU): Cost-Effectiveness Analysis

J Med Internet Res.

Del Hoyo J, Nos P, Bastida G, Faubel R, Muñoz D, Garrido-Marín A, Valero-Pérez E, Bejar-Serrano S, Aguas M

doi: 10.2196/15505.

Related content

Frequency and type of drug-related side effects necessitating treatment discontinuation in the Swiss Inflammatory Bowel Disease Cohort

Adverse Events and Nocebo Effects in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Predicting, Preventing, and Managing Treatment-related Complications in Patients With Inflammatory Bowel Diseases

Histologic Healing Rates of Medical Therapies for Ulcerative Colitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Misoprostol for small bowel ulcers in patients with obscure bleeding taking aspirin and non-steroidal anti-inflammatory drugs (MASTERS): a randomised, double-blind, placebo-controlled, phase 3 trial

Helicobacter pylori increases the risk of low-dose aspirin ulcers: A meta-analysis

Helicobacter pylori-associated peptic ulcer disease: A retrospective analysis of post-treatment testing practices

Benefit-Risk Assessment of Vedolizumab in the Treatment of Crohn's Disease and Ulcerative Colitis

Telemonitoring of Crohn's Disease and Ulcerative Colitis (TECCU): Cost-Effectiveness Analysis